Literature DB >> 20098187

Kasabach-Merritt syndrome with partial resection of tumor, reduction of tumor blood, and vincristine chemotherapy.

Weiming Shen1, Jie Cui, Jianbin Chen, Jijun Zou, Yi Ji, Haini Chen.   

Abstract

Kasabach-Merritt syndrome is a life-threatening and localized consumptive coagulopathy and characterized by profound thrombocytopenia and microangiopathic anemia. The huge tumor is the major cause of rapid platelet destruction, so we supposed that the reduction of tumor could reduce the platelet destruction and improve the clinical condition. In our cases, the vascular tumor occupied one of the extremities, head or face; however, removal of the whole tumor will result in the amputation of this extremity or the destruction of the face, and partial removal of the tumor and a U-shape suture to reduce tumor blood supply will be suitable. The wound could be repaired with skin graft or flaps. Vincristine chemotherapy after operation is necessary to prevent the enlargement of the remaining tumor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098187     DOI: 10.1097/SCS.0b013e3181c51138

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

Review 1.  Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.

Authors:  Irene Schmid; Anne K Klenk; Monika Sparber-Sauer; Ewa Koscielniak; Rebecca Maxwell; Beate Häberle
Journal:  World J Pediatr       Date:  2018-07-27       Impact factor: 2.764

Review 2.  MR imaging characteristics of soft tissue vascular anomalies in children.

Authors:  Shrey K Thawait; Kate Puttgen; John A Carrino; Laura M Fayad; Sally E Mitchell; Thierry A G M Huisman; Aylin Tekes
Journal:  Eur J Pediatr       Date:  2012-09-18       Impact factor: 3.183

3.  Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature.

Authors:  Si-Ming Yuan; Wei-Min Shen; Hai-Ni Chen; Zhi-Jian Hong; Hui-Qing Jiang
Journal:  Int J Clin Exp Med       Date:  2015-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.